Biostatistics Biostatistics is a vital component of all aspects of well designed cancer research. The Biostatistics Core provides HCCC investigators with a shared resource that assists with study design and statistical analysis of basic, clinical, and population-based studies. The core includes four experienced biostatisticians, and promotes and maintains an environment in which HCCC investigators feel free to involve the Biostatistics Core at all stages of research activity where statistical input might be beneficial. The Biostatistics core 1) Collaborates with HCCC investigators in the design of clinical, epidemiologic, basic science research and quality of life projects 2) Collaborates with HCCC investigators in the analysis of data from clinical, epidemiologic, and basic science projects 3) Conducts and participates in educational programs for investigators, faculty, fellows, students and staff of the HCCC 4) Supports the protocol review and study monitoring activities of the HCCC The Biostatistics Core also takes advantage of additional expertise found in the Department of Biostatistics at the University of lowa College of Public Health and collaborates closely with the newly established Bioinformatics Shared Resource. In 2009, 44 HCCC members for all 6 programs utilized the Biostatistics Core.
Rigorous biostatistics is central to all aspects of cancer research. The Biostatistics Core plays a central role in both the design and analysis of basic, clinical, and population-based cancer research.
|Liu, Q; Kulak, M V; Borcherding, N et al. (2018) A novel HER2 gene body enhancer contributes to HER2 expression. Oncogene 37:687-694|
|Arthur, Rhonda; Wassertheil-Smoller, Sylvia; Manson, JoAnn E et al. (2018) The Combined Association of Modifiable Risk Factors with Breast Cancer Risk in the Women's Health Initiative. Cancer Prev Res (Phila) 11:317-326|
|Press, Robert H; Shu, Hui-Kuo G; Shim, Hyunsuk et al. (2018) The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective. Int J Radiat Oncol Biol Phys 102:1219-1235|
|Viala, Marie; Chiba, Akiko; Thezenas, Simon et al. (2018) Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study. BMC Cancer 18:770|
|Madsen, Mark T; Menda, Yusuf; O'Dorisio, Thomas M et al. (2018) Technical Note: Single time point dose estimate for exponential clearance. Med Phys 45:2318-2324|
|Luchtel, Rebecca A; Dasari, Surendra; Oishi, Naoki et al. (2018) Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Blood 132:1386-1398|
|Sabree, Shakoora; Berg, Daniel; Sato, Mariko (2018) Treatment of a pediatric patient with MET-amplified signet ring cell adenocarcinoma of the stomach with crizotinib. Pediatr Blood Cancer 65:e26984|
|Bharti, Sanjay Kumar; Sommers, Joshua A; Awate, Sanket et al. (2018) A minimal threshold of FANCJ helicase activity is required for its response to replication stress or double-strand break repair. Nucleic Acids Res 46:6238-6256|
|Reiner, Anne S; Sisti, Julia; John, Esther M et al. (2018) Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 36:1513-1520|
|Leelakanok, Nattawut; Geary, Sean; Salem, Aliasger (2018) Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil. J Pharm Sci 107:513-528|
Showing the most recent 10 out of 1080 publications